Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3Sarcoma 1

Conditions

Fatigue 18cyclopia sequence 4Neoplasms 4Glioma 3Central Nervous System Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 3Sleepiness 2Sleep Initiation and Maintenance Disorders 2Pain 2Lung Neoplasms 2Head and Neck Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 1Sleep Wake Disorders 1Parasomnias 1Oligodendroglioma 1Neurotoxicity Syndromes 1Nervous System Neoplasms 1Meningioma 1Lymphoma, B-Cell 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Laryngeal Diseases 1Gliosarcoma 1Glioma, Subependymal 1Glioblastoma 1Esophageal Neoplasms 1Ependymoma 1Disorders of Excessive Somnolence 1Cognitive Dysfunction 1Cognition Disorders 1

Interventions

Temozolomide 109Magnetic Resonance Spectroscopy 52Bevacizumab 52Radiotherapy 44Irinotecan 27Blood Specimen Collection 19Surgical Procedures, Operative 16Radiation 15Aminolevulinic Acid 15Carboplatin 13fluorodopa F 18 12Nivolumab 12Radiotherapy, Intensity-Modulated 11Carmustine 11Radiosurgery 10Magnetic Resonance Imaging 10pembrolizumab 9Topotecan 9Specimen Handling 9Everolimus 9Erlotinib Hydrochloride 9Biopsy 9poly ICLC 8Surveys and Questionnaires 8Standard of Care 8Etoposide 8Drug Therapy 8Lomustine 7Filgrastim 7Cyclophosphamide 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Glioma × Modafinil × Clear all
NCT01032200 2021-09-28

Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors

Wake Forest University Health Sciences

Phase 2 Completed
54 enrolled 14 charts
CNSSarcoma

Astrocytoma, Brain Neoplasms, Cognition Disorders, Ependymoma, Fatigue, Glioblastoma, Glioma, Meningioma, Nervous System Neoplasms, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

NCT00766467 2016-07-28

A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas

Dana-Farber Cancer Institute

Phase 2 Completed
81 enrolled 9 charts
CNS

Fatigue, Glioma

NCT01400958 2013-12-16

Nuvigil or Placebo in Newly Diagnosed Malignant Glioma

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Terminated
6 enrolled 8 charts
CNS

Fatigue, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡